loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Cidofovir (anhydrous)

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    cidofovir anhydrous

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 169,674Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Takeda’s LIVTENCITY Available for Certain Individuals Ages 12 Years and Older
    Takeda’s LIVTENCITY Available for Certain Individuals Ages 12 Years and Older

    02 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211202005653/en

    BUSINESSWIRE
    02 Dec 2021
    Share Share
    Takeda’s LIVTENCITYTM Approved by FDA in CMV; & more
    Takeda’s LIVTENCITYTM Approved by FDA in CMV; & more

    23 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211123006185/en

    BUSINESSWIRE
    23 Nov 2021
    Share Share
    FDA's ADAC unanimously backs Takeda's drug for post-transplant cytomegalovirus
    FDA's ADAC unanimously backs Takeda's drug for post-transplant cytomegalovirus

    08 Oct 2021

    // Z. Brennan ENDPTS

    https://endpts.com/fdas-antimicrobial-adcomm-unanimously-backs-takedas-drug-for-post-transplant-cytomegalovirus/

    Z. Brennan ENDPTS
    08 Oct 2021
    Share Share
    Enforcement Report - Week of January 16, 2019
    Enforcement Report - Week of January 16, 2019

    16 Jan 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-16-2019-1547641914.pdf

    FDA
    16 Jan 2019
    Share Share
    Enforcement Report - Week of October 31, 2018
    Enforcement Report - Week of October 31, 2018

    31 Oct 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-October-31-2018-1540974685.pdf

    FDA
    31 Oct 2018
    Share Share
    DOJ's price-fixing investigation could lead to sizable liabilities, analyst says
    DOJ's price-fixing investigation could lead to sizable liabilities, analyst says

    10 Nov 2016

    // Eric Sagonowsky FIERCE PHARMA

    http://www.fiercepharma.com/pharma/doj-s-price-fixing-investigation-could-lead-to-sizable-liabilities-analyst-says

    Eric Sagonowsky FIERCE PHARMA
    10 Nov 2016
    Share Share